Newsletter
Industry Watch
In our first issue of Industry Watch for 2021, we’re bringing our readers insights from a founding member of the Human Genome Project, looking at…
All Results
Newsletter
Blog
A PRA Expert’s Experience Treating the First Pediatric Patient to Receive CAR T-Cell Therapy
Emily Whitehead was born on May 2nd of 2005, a perfectly healthy baby. When she reached five, her parents noticed bruising on her legs, bleeding…
Blog
PRA Health Sciences' 2nd Annual Celebration of World Children’s Day
Children and young adults across the globe are largely underrepresented in clinical research. While legal actions such as the Research to Accelerate…
Newsletter
Industry Watch
In the first week of November, Industry Watch brings you news of strategies to improve cancer screening via novel multi-cancer early detection (MCED)…
Blog
Demystifying Pediatric Clinical Research for Emerging Biotech
A substantial change to the drug development landscape is currently underway. Regulatory authorities are starting to acknowledge pediatrics as one of…
Newsletter
Pediatrics Newsletter
Welcome to the third edition of the Center for Pediatric Clinical Development (CPCD) newsletter. This quarterly publication will keep you informed on…
White Paper
The RACE for Children Act: How Industry Can Accelerate Readiness Through Collaboration With Patient Organizations
This whitepaper offers a high-level orientation around the key barriers to readiness and critical success factors for companies navigating the…
Blog
What Does the Future of Childhood Cancer Treatment Look Like?
Now that the RACE for Children Act has come into effect, the drug development industry and patients and their families are optimistic—more drugs will…
Case Study
Collaboration Advances Small Pharma Company’s Pediatric Development Plan to First-in-Pediatrics RSV Study
A Phase II, randomized, double-blind, placebo-controlled, 2-part study to evaluate the safety, tolerability, pharmacokinetics, clinical response, and…
Blog
LLS PedAL: How Collaboration in Pediatric Oncology Trials Will Lead to Success
PRA has partnered with The Leukemia and Lymphoma Society (LLS) on a global precision medicine clinical trial for children with relapsed acute…